<DOC>
	<DOCNO>NCT01145898</DOCNO>
	<brief_summary>To analyze Cosopt® term effect ocular perfusion pressure comprehensive ocular blood flow relation visual field progression optic nerve structural change ongoing 3 year prospective study involve 120 patient open angle glaucoma .</brief_summary>
	<brief_title>Trusopt Cosopt ; Ocular Perfusion Pressure Blood Flow : New Long-term Prospective Data</brief_title>
	<detailed_description>To analyze Cosopt® term effect ocular perfusion pressure comprehensive ocular blood flow relation visual field progression optic nerve structural change ongoing 3 year prospective study involve 120 patient open angle glaucoma .</detailed_description>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Dorzolamide</mesh_term>
	<criteria>1 . Age : 30 year old . 2 . Diagnosis : confirm openangle glaucoma least one eye : 1. glaucomatous visual field loss Humphrey 242 102 perimetry 2. glaucomatous optic disc cup 3. agreement two baseline exam reliability 3 . Best correct visual acuity least 20/60 least one eye . 4 . Prior Humphrey visual field demonstrate acceptable reliability standard . 1 . Extensive Humphrey visual field damage consist either mean deviation ( MD ) &lt; 15 decibel clinically determine threat fixation hemifields . 2 . Evidence exfoliation pigment dispersion . 3 . History acute angleclosure narrow , occludable anterior chamber angle gonioscopy . 4 . History chronic recurrent inflammatory eye disease ( e.g. , scleritis , uveitis ) . 5 . History sign intraocular trauma . 6 . Severe potentially progressive retinal disease retinal degeneration , diabetic retinopathy , retinal detachment . 7 . Any abnormality prevent reliable applanation tonometry . 8 . Current use ophthalmic systemic steroid may interfere investigation . 9 . Cataract surgery within past year . 10 . Resting pulse &lt; 50 beat per minute . 11 . Severe , unstable uncontrolled cardiovascular , renal , pulmonary disease .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Glaucoma</keyword>
	<keyword>Cosopt</keyword>
	<keyword>blood flow</keyword>
	<keyword>progression</keyword>
</DOC>